REFRACTORY MYCOSIS FUNGOIDES
Clinical trials for REFRACTORY MYCOSIS FUNGOIDES explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY MYCOSIS FUNGOIDES trials appear
Sign up with your email to follow new studies for REFRACTORY MYCOSIS FUNGOIDES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Virus-Based therapy targets Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase trial tests a genetically modified virus (VSV-IFNβ-NIS) alone or with chemotherapy and immunotherapy drugs in people with blood cancers like multiple myeloma, acute myeloid leukemia, and lymphomas that have returned or not responded to treatment. The virus is des…
Matched conditions: REFRACTORY MYCOSIS FUNGOIDES
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New study aims to decode cancer drug rash mystery
Knowledge-focused Recruiting nowThis study looks at a common skin rash caused by the cancer drug mogamulizumab in people with mycosis fungoides or Sezary syndrome (types of blood cancer). The rash can look like the cancer itself, leading doctors to stop treatment too early. Researchers want to learn how to tell…
Matched conditions: REFRACTORY MYCOSIS FUNGOIDES
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated May 26, 2026 04:31 UTC